Health care costs attributable to the treatment of rheumatoid arthritis

Scandinavian Journal of Rheumatology

Volumn 33, Issue 6, 2004, Pages 399-404

  Sørensen, Jan ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DENMARK; GROUPS BY AGE; HEALTH CARE COST; HOSPITAL CARE; HUMAN; MORTALITY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REGISTER; RESOURCE ALLOCATION; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; COST OF ILLNESS; COST SAVINGS; DENMARK; FEMALE; HEALTH CARE COSTS; HEALTH RESOURCES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; SURVIVAL RATE;

EID: 10844268626     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740410006880     Document Type: Article

References (16)

1. Summary and conclusions. In: National Board of Health, Danish Centre for Evaluation and Health Technology Assessment. Rheumatoid Arthritis - Health technology assessment of diagnosis and treatment. Copenhagen: National Board of Health, 2002:23-25.
2. Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Direct medical costs unique to people with arthritis. J Rheumatol 1997;24:719-25.
3. Allaire SH, Prashker MJ, Meenan RF. The costs of rheumatoid arthritis. Pharmacoeconomics 1994;6:513-22.
4. Cooper NJ. Economic burden of rheumatoid arthritis: a systematic review. Rheumatology (Oxford) 2000;39:28-33.
5. McIntosh E. The cost of rheumatoid arthritis. Br J Rheumatol 1996;35:781-90.
6. Smith MD, McGhan WF. Economic pains of rheumatoid arthritis. Bus Health 1997;15:55-6, 58.
7. Bloom BS, Bruno DJ, Maman DY, Jayadevappa R. Usefulness of US cost-of-illness studies in healthcare decision making. Pharmacoeconomics 2001;19:207-13.
8. Drummond M. Cost-of-illness studies: a major headache? Pharmacoeconomics 1992;2:1-4.
9. Shiell A, Gerard K, Donaldson C. Cost of illness studies: an aid to decision making? Health Policy 1987;8:317-23.
10. Clarke AE, Zowall H, Levinton C, Assimakopoulos H, Sibley JT, Haga M, et al. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12-year study. J Rheumatol 1997;24:1051-60.
11. Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Indirect and non-medical costs among people with rheumatoid arthritis and osteoarthritis compared with non-arthritic controls. J Rheumatol 1997;24:43-8.
12. Gabriel SE, Crowson CS, Luthra HS, Wagner JL, O'Fallon WM. Modelling the lifetime costs of rheumatoid arthritis. J Rheumatol 1999;26:1269-74.
13. Ratcliffe J, Donaldson C, Macphee S. Programme budgeting and marginal analysis: a case study of maternity services. J Public Health Med 1996;18:175-82.
14. Mooney G. Programme budgeting: an aid to planning and priority setting in health care. Eff Health Care 1984;2:65-8.
15. Mitton C, Donaldson C. Twenty-five years of programme budgeting and marginal analysis in the health sector, 1974-1999. J Health Serv Res Policy 2001;6:239-48.
16. Nymark T, Thomsen K, Rock ND. Diagnosis and procedure coding in relation to the DRG system. Ugeskr Laeger 2003;165:207-9.